ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
77.87
+0.15 (0.19%)
Jul 21, 2026, 10:06 AM EDT - Market open
ANI Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 923.71 | 883.37 | 614.38 | 486.82 | 316.39 | 216.14 | |
Revenue Growth (YoY) | 37.04% | 43.78% | 26.20% | 53.87% | 46.38% | 3.67% |
Cost of Revenue | 361.86 | 341.31 | 250.21 | 181.51 | 138.79 | 100.61 |
Gross Profit | 561.85 | 542.06 | 364.17 | 305.3 | 177.6 | 115.53 |
Selling, General & Admin | 314.87 | 317.75 | 249.64 | 161.7 | 124.04 | 84.29 |
Depreciation & Amortization Expenses | 89.45 | 91.42 | 67.73 | 59.79 | 56.97 | 47.25 |
Research & Development | 51.7 | 51.66 | 44.58 | 34.29 | 22.32 | 11.37 |
Other Operating Expenses | -19.1 | -29.86 | 12.33 | 2.56 | 9.55 | 12.4 |
Total Operating Expenses | 436.92 | 430.96 | 374.28 | 258.33 | 212.88 | 155.32 |
Operating Income | 123.79 | 111.09 | 0.58 | 46.97 | -35.28 | -39.79 |
Interest Expense | -18.35 | -20.06 | -17.6 | -26.94 | -28.05 | -11.92 |
Other Non-Operating Income (Expense) | 1.09 | 4.76 | -16.85 | -0.16 | 0.67 | -4.34 |
Total Non-Operating Income (Expense) | -17.26 | -15.3 | -34.45 | -27.1 | -27.38 | -16.27 |
Pretax Income | 116.03 | 95.79 | -22.21 | 19.87 | -62.67 | -56.06 |
Provision for Income Taxes | 23.88 | 17.45 | -3.69 | 1.09 | -14.77 | -13.46 |
Net Income | 92.15 | 78.34 | -18.52 | 18.78 | -47.9 | -42.6 |
Net Income Attributable to Preferred Dividends | - | 1.16 | - | - | - | - |
Net Income to Common | 92.15 | 77.18 | -18.52 | 18.78 | -47.9 | -42.6 |
Shares Outstanding (Basic) | 20 | 20 | 19 | 18 | 16 | 13 |
Shares Outstanding (Diluted) | 21 | 21 | 19 | 18 | 16 | 13 |
Shares Change (YoY) | 7.01% | 9.89% | 6.18% | 11.89% | 29.77% | 4.73% |
EPS (Basic) | 4.11 | 3.50 | -1.04 | 0.86 | -3.05 | -3.40 |
EPS (Diluted) | 3.95 | 3.32 | -1.04 | 0.85 | -3.05 | -3.40 |
Free Cash Flow | - | 0 | 47.78 | 110.09 | -40.08 | 0.77 |
Free Cash Flow Growth | - | - | -56.60% | - | - | -91.62% |
Free Cash Flow Per Share | - | - | 2.47 | 6.05 | -2.46 | 0.06 |
Gross Margin | 60.83% | 61.36% | 59.27% | 62.71% | 56.13% | 53.45% |
Operating Margin | 13.40% | 12.58% | 0.10% | 9.65% | -11.15% | -18.41% |
Profit Margin | 9.98% | 8.87% | -3.01% | 3.86% | -15.14% | -19.71% |
FCF Margin | - | 0.00% | 7.78% | 22.61% | -12.67% | 0.35% |
EBITDA | 123.79 | 111.09 | 68.32 | 106.76 | 24.37 | 7.46 |
EBITDA Margin | 13.40% | 12.58% | 11.12% | 21.93% | 7.70% | 3.45% |
EBIT | 123.79 | 111.09 | 0.58 | 46.97 | -35.28 | -39.79 |
EBIT Margin | 13.40% | 12.58% | 0.10% | 9.65% | -11.15% | -18.41% |
Effective Tax Rate | 20.58% | 18.22% | 16.61% | 5.50% | 23.57% | 24.00% |